z-logo
Premium
Micro RNA ‐146a represses LRP 2 translation and leads to cell apoptosis in Alzheimer's disease
Author(s) -
Zhang Bei,
Wang LiLing,
Ren RuJing,
Dammer Eric B.,
Zhang YongFang,
Huang Yue,
Chen ShengDi,
Wang Gang
Publication year - 2016
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1002/1873-3468.12229
Subject(s) - rna , downregulation and upregulation , rna binding protein , translation (biology) , messenger rna , protein kinase b , microbiology and biotechnology , apoptosis , chemistry , cell , receptor , antisense rna , cancer research , biology , gene , biochemistry
Micro RNA regulation of transcript expression has been reported in patients with Alzheimer's disease ( AD ). Here, we investigate the role of micro RNA ‐146a (mi RNA ‐146a), a brain‐enriched mi RNA , which is upregulated in AD patients. Through analysis of predicted targets of mi RNA ‐146a, low‐density lipoprotein receptor‐related protein‐2 (Lrp2), a member of the LDLR family that is known to play a protective role in AD , was identified. Overexpression of mi RNA ‐146a in SH ‐ SY 5Y cells significantly decreased Lrp2 expression, resulting in a reduction of Akt activation and induction of proapoptotic caspase‐3, thereby increasing cell apoptosis. Thus, specific mi RNA ‐146a regulation may contribute to AD by downregulating the Lrp2/Akt pathway.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom